{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:00:54Z","timestamp":1783418454362,"version":"3.54.6"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/ejcts\/ezx295","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T03:11:16Z","timestamp":1501038676000},"page":"372-378","source":"Crossref","is-referenced-by-count":10,"title":["Invasive features of small-sized lung adenocarcinoma adjoining emphysematous bullae"],"prefix":"10.1093","volume":"53","author":[{"given":"Gouji","family":"Toyokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Haratake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinkichi","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"key\n\t\t\t\t20180116044112_ezx295-B1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)","volume":"6","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jjco\/hyp156","article-title":"A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802\/WJOG4607L)","volume":"40","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/icvts\/ivv124","article-title":"Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study","volume":"21","year":"2015","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B6","first-page":"1062","article-title":"Bronchogenic carcinoma and giant bullous disease","volume":"97","year":"1968","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-5002(02)00186-1","article-title":"Primary lung carcinoma arising from emphysematous bullae","volume":"38","year":"2002","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jtho.2016.04.024","article-title":"Characteristics of smoking patients with lung cancer with emphysematous bullae","volume":"11","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.23.4.403","article-title":"The correlation of carcinoma and congenital cystic emphysema of the lungs: report of ten cases","volume":"23","year":"1953","journal-title":"Dis Chest"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B10","doi-asserted-by":"crossref","first-page":"186.","DOI":"10.1016\/S0022-5223(19)33764-X","article-title":"Bullae and lung cancer","volume":"106","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/00039896.1971.10665827","article-title":"The risk of lung cancer in males with bullous disease of the lung","volume":"22","year":"1971","journal-title":"Arch Environ Health"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0003-4975(10)64733-9","article-title":"Characteristic radiographic features of pulmonary carcinoma associated with large bulla","volume":"46","year":"1988","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B13","article-title":"High frequency of programmed death-ligand 1 expression in emphysematous bullae-associated lung adenocarcinomas","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B14","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1158\/1078-0432.CCR-13-2683","article-title":"Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations","volume":"20","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","article-title":"Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma","volume":"11","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jtho.2016.04.007","article-title":"Prognostic significance of programmed cell death ligand 1 in patients with non-small-cell lung cancer: a large cohort study of surgically resected cases","volume":"11","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/1744666X.2013.828875","article-title":"Immune response in chronic obstructive pulmonary disease","volume":"9","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer","volume":"112","year":"2015","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B20","first-page":"200ra116.","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","year":"2013","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/annonc\/mdu242","article-title":"Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1470-2045(15)00307-1","article-title":"PD-L1 expression as a potential predictive biomarker","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B24","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","article-title":"Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa032792","article-title":"A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B26","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B28","first-page":"208","article-title":"PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project","volume":"12","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20180116044112_ezx295-B29","first-page":"3409","article-title":"An immunohistochemical analysis of PD-L1 protein expression in surgically resected small cell lung cancer using different antibodies and criteria","volume":"36","year":"2016","journal-title":"Anticancer Res"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/2\/372\/23529608\/ezx295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T11:52:53Z","timestamp":1602589973000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ejcts\/article\/53\/2\/372\/4096821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezx295","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,8,29]]}}}